APP and Alzheimer disease: Together, these data indicate that PGRN has a potential role in Abeta deposition and clearance through the immune system, mainly microglial cells; hence, several studies have aimed to increase PGRN levels as a way to improve AD-like pathology in mice [179, 181, 182].